ECU
ABBV icon

Eisler Capital (US)’s AbbVie ABBV Stock Holding History

Eisler Capital (US)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$16M Sell
80,900
-76,900
-49% -$14.4M 0.34% 75
2024
Q2 		$27.1M Buy
157,800
+105,200
+200% +$17.4M 0.48% 41
2024
Q1 		$9.58M Sell
52,600
-13,300
-20% -$2.29M 0.24% 89
2023
Q4 		$10.2M Sell
65,900
-59,100
-47% -$8.62M 0.32% 74
2023
Q3 		$18.6M Buy
125,000
+100,300
+406% +$14.7M 0.47% 38
2023
Q2 		$3.33M Buy
24,700
+16,000
+184% +$2.35M 0.12% 151
2023
Q1 		$1.39M Buy
+8,700
New +$1.33M 0.11% 131

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Eisler Capital (US)'s ABBV Position: Q3 2024 in Review

Eisler Capital (US) reduced its AbbVie (ABBV) stake by 62% in Q3 2024, selling an estimated $2.83M and leaving 9,297 shares worth $1.84M. The position accounts for 0.04% of the portfolio, ranked #329.

Eisler Capital (US) first reported a position in ABBV in Q1 2023 and has held it in 5 quarters since. The position peaked at $5.72M in Q2 2023. 3,500 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • Eisler Capital (US) held 9,297 shares of AbbVie worth $1.84M as of Q3 2024.
  • Eisler Capital (US) sold 15,170 AbbVie shares in Q3 2024, an estimated $2.83M.
  • AbbVie made up 0.04% of Eisler Capital (US)'s portfolio in Q3 2024, its #329 holding.
  • Eisler Capital (US) first reported a position in AbbVie in Q1 2023 and has held it in 5 quarters since.
  • Eisler Capital (US)'s AbbVie position peaked at $5.72M in Q2 2023.
  • 3,500 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on Eisler Capital (US)'s 13F filing for Q3 2024, filed 14 Nov 2024.